Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive preliminary response rate reported for RSR-13 in NSCLC

Dec. 1, 2000

Bristol-Myers Squibb seeks FDA approval to begin systemic CA4P trials

Dec. 1, 2000

Abgenix and Immunex join forces for development of anticancer antibodies

Dec. 1, 2000

Scotia submits additional data to FDA for Foscan NDA

Nov. 30, 2000

U.K. scientists investigate novel series of antitumor agents

Nov. 30, 2000

Maxim receives SBIR grant for development of caspase-inducing drugs

Nov. 30, 2000

FeRx and Elan to develop MTC-DOX for treatment of liver cancer

Nov. 30, 2000

Deltagen obtains license to develop potential AML treatment

Nov. 30, 2000

Enhanced expression of p21 associated with responses to rAd-p53 gene therapy in NSCLC

Nov. 29, 2000

PK-11195 is able to sensitize cholangiocarcinoma cells to radiation-induced apoptosis

Nov. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026